Primary hyperfibrinolysis as the presenting sign of prostate cancer: A case report | Zendy

Andrijana Kulic | Zendy; Zorica Cvetković | Zendy; Vesna Libek | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Primary hyperfibrinolysis as the presenting sign of prostate cancer: A case report

Author(s) -

Andrijana Kulic,

Zorica Cvetković,

Vesna Libek

Publication year - 2016

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp150525076k

Subject(s) - hyperfibrinolysis , medicine , prostate cancer , sign (mathematics) , primary (astronomy) , oncology , cancer , fibrinolysis , mathematics , astronomy , mathematical analysis , physics

A bleeding syndrome in the setting of primary hyperfibrinolysis in a prostate cancer patient is only 0.40– 1.65% of cases. The laboratory diagnosis of primary hyperfibrinolysis is based on the increase of biomarkers like D-dimer, fibrinogen split products, plasminogen, and euglobulin lysis test. These tests are not specific for primary hyperfibrinolysis. We reported a rare case of hemorrhagic syndrome caused by primary hyperfibrinolysis as the first clinical symptom of metastatic prostate cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research